Novo Nordisk says its obesity drug in higher dose shows 20.7% weight loss
Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...
New Scientist on MSN2d
A new definition of obesity could help treat millions of people
Obesity is typically assessed by measuring someone's body mass index, but now researchers are calling for a more nuanced ...
The Economist2d
Is obesity a disease?
By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that ...
New recommendations to measure obesity go beyond controversial BMI. A doctor explains.
Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts ...
New report proposes redefining obesity by adding body fat and health status to BMI
New guidance from a team of health experts around the world proposes expanding the definition of obesity beyond the popular ...
BioPharma Dive18m
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
Air quality impacts baby’s future even before you’re pregnant
The findings were published in the journal Environmental Research. Researchers from ...
This disease is known as the ‘silent killer.’ A doctor explains why
People often let chronic conditions such as high blood pressure and diabetes go for a long time without treatment. Here’s why you should address them before symptoms begin.